Search Results

There are 34146 results for: content related to: Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist

  1. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period

    Allergy

    Volume 58, Issue 12, December 2003, Pages: 1268–1276, J. Van Adelsberg, G. Philip, A. J. Pedinoff, E. O. Meltzer, P. H. Ratner, J. Menten, T. F. Reiss and for the Montelukast Fall Rhinitis Study Group

    Version of Record online : 3 NOV 2003, DOI: 10.1046/j.1398-9995.2003.00261.x

    Corrected by:

    Corrigendum

    Vol. 64, Issue 11, 1697, Version of Record online: 8 OCT 2009

  2. Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 1, February 2012, Pages: 112–116, H. Kotani, R. Kishi, A. Mouri, T. Sashio, J. Shindo, A. Shiraki, T. Hiramatsu, S. Iwata, H. Taniguchi, O. Nishiyama, M. Iwata, R. Suzuki, H. Gonda, T. Niwa, M. Kondo, Y. Hasegawa, H. Kume and Y. Noda

    Version of Record online : 9 MAR 2011, DOI: 10.1111/j.1365-2710.2011.01248.x

  3. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

    Clinical & Experimental Allergy

    Volume 32, Issue 7, July 2002, Pages: 1020–1028, G. Philip, K. Malmstrom, F. C. Hampel Jr, S. F. Weinstein, C. F. LaForce, P. H. Ratner, M.-P. Malice, T. F. Reiss and for the Montelukast Spring Rhinitis Study Group

    Version of Record online : 5 JUL 2002, DOI: 10.1046/j.1365-2222.2002.01422.x

  4. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma

    Clinical & Experimental Allergy

    Volume 32, Issue 9, September 2002, Pages: 1360–1365, L. Mastalerz, A. Gawlewicz-Mroczka, E. Nizankowska, A. Cmiel and A. Szczeklik

    Version of Record online : 6 SEP 2002, DOI: 10.1046/j.1365-2745.2002.01484.x

  5. Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction

    Scandinavian Journal of Medicine & Science in Sports

    Volume 12, Issue 4, August 2002, Pages: 211–217, S. Steinshamn, M. Sandsund, M. Sue-Chu and L. Bjermer

    Version of Record online : 29 AUG 2002, DOI: 10.1034/j.1600-0838.2002.00225.x

  6. You have free access to this content
    Add-on therapy with montelukast or formoterol in patients with the glycine-16 β2-receptor genotype

    British Journal of Clinical Pharmacology

    Volume 56, Issue 1, July 2003, Pages: 104–111, Erika J. Sims, Catherine M. Jackson and Brian J. Lipworth

    Version of Record online : 9 JUL 2003, DOI: 10.1046/j.1365-2125.2003.01899.x

  7. You have free access to this content
    Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism

    British Journal of Pharmacology

    Volume 156, Issue 1, January 2009, Pages: 105–115, Ronald Anderson, Annette J Theron, Cornelia M Gravett, Helen C Steel, Gregory R Tintinger and Charles Feldman

    Version of Record online : 5 DEC 2008, DOI: 10.1111/j.1476-5381.2008.00012.x

  8. You have free access to this content
    Allergic Rhinitis and its Impact on Asthma (ARIA) 2008

    Allergy

    Volume 63, Issue s86, April 2008, Pages: 8–160, J. Bousquet, N. Khaltaev, A. A. Cruz, J. Denburg, W. J. Fokkens, A. Togias, T. Zuberbier, C. E. Baena-Cagnani, G. W. Canonica, C. Van Weel, I. Agache, N. Aït-Khaled, C. Bachert, M. S. Blaiss, S. Bonini, L.-P. Boulet, P.-J. Bousquet, P. Camargos, K.-H. Carlsen, Y. Chen, A. Custovic, R. Dahl, P. Demoly, H. Douagui, S. R. Durham, R. Gerth Van Wijk, O. Kalayci, M. A. Kaliner, Y.-Y. Kim, M. L. Kowalski, P. Kuna, L. T. T. Le, C. Lemiere, J. Li, R. F. Lockey, S. Mavale-Manuel, E. O. Meltzer, Y. Mohammad, J. Mullol, R. Naclerio, R. E. O’Hehir, K. Ohta, S. Ouedraogo, S. Palkonen, N. Papadopoulos, G. Passalacqua, R. Pawankar, T. A. Popov, K. F. Rabe, J. Rosado-Pinto, G. K. Scadding, F. E. R. Simons, E. Toskala, E. Valovirta, P. Van Cauwenberge, D.-Y. Wang, M. Wickman, B. P. Yawn, A. Yorgancioglu, O. M. Yusuf, H. Zar, I. Annesi-Maesano, E. D. Bateman, A. Ben Kheder, D. A. Boakye, J. Bouchard, P. Burney, W. W. Busse, M. Chan-Yeung, N. H. Chavannes, A. Chuchalin, W. K. Dolen, R. Emuzyte, L. Grouse, M. Humbert, C. Jackson, S. L. Johnston, P. K. Keith, J. P. Kemp, J.-M. Klossek, D. Larenas-Linnemann, B. Lipworth, J.-L. Malo, G. D. Marshall, C. Naspitz, K. Nekam, B. Niggemann, E. Nizankowska-Mogilnicka, Y. Okamoto, M. P. Orru, P. Potter, D. Price, S. W. Stoloff, O. Vandenplas, G. Viegi and D. Williams

    Version of Record online : 7 MAR 2008, DOI: 10.1111/j.1398-9995.2007.01620.x

  9. You have free access to this content
    Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis

    Hepatology

    Volume 51, Issue 6, June 2010, Pages: 2086–2096, Christian J. Steib, Manfred Bilzer, Mark op den Winkel, Susanne Pfeiler, Anna C. Hartmann, Martin Hennenberg, Burkhard Göke and Alexander L. Gerbes

    Version of Record online : 19 FEB 2010, DOI: 10.1002/hep.23596

  10. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children

    Intervention Review

    The Cochrane Library

    Bhupendrasinh F Chauhan and Francine M Ducharme

    Published Online : 16 MAY 2012, DOI: 10.1002/14651858.CD002314.pub3

  11. Clinical efficacy of montelukast in adults and children

    Clinical & Experimental Allergy Reviews

    Volume 1, Issue 3, November 2001, Pages: 264–273, T. F. Reiss, B. Knorr, K. Malmstrom, G. Noonan and S. Lu

    Version of Record online : 7 MAY 2002, DOI: 10.1046/j.1472-9725.2001.t01-1-00012.x

  12. You have free access to this content
    Apple juice greatly reduces systemic exposure to atenolol

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 172–179, Hyewon Jeon, In-Jin Jang, SeungHwan Lee, Kyoichi Ohashi, Tsutomu Kotegawa, Ichiro Ieiri, Joo-Youn Cho, Seo Hyun Yoon, Sang-Goo Shin, Kyung-Sang Yu and Kyoung Soo Lim

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04324.x

  13. You have free access to this content
    Substance Overview for Formic acid methyl ester

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe10731

  14. You have free access to this content
    Substance Overview for Perfluorooctanoic acid and its inorganic salts

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe33567

  15. You have free access to this content
    Substance Overview for 2-Diethylaminoethanol

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe10037

  16. You have free access to this content
    Substance Overview for N,N-Dimethylaniline

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe12169

  17. You have free access to this content
    Substance Overview for Ethylene oxide

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe7521

  18. You have free access to this content
    Substance Overview for Sulfur monochloride

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe1002567

  19. You have free access to this content
    Substance Overview for Cyfluthrin

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe6835937

  20. You have free access to this content
    Substance Overview for Desflurane

    Short article

    The MAK Collection for Occupational Health and Safety

    Published Online : 31 JAN 2012, DOI: 10.1002/3527600418.mbe5704167